Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Mathilde Rauline has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 14, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305415

Use of an h3 receptor antagonist for the treatment of alzheimer's disease

IPC classification:
A61P 25/00, A61K 31/4725
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION REFUSED
EP12305130

2-(3-aminophenoxy)-acetic acid derivatives as EP2 receptor agonists for use in treatment of glaucoma

IPC classification:
A61K 31/196, A61P 27/02, C07C 217/84
Applicant:
Fovea Pharmaceuticals SA
Agent:
Mathilde Rauline, Sanofi
Agent:
Claude Jacobson, Cabinet Lavoix
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature